Lukas Bubendorf

September Webinar 2022: Dr. Lukas Bubendorf

August Webinar 2022: Dr. William C. Faquin, MD, PhD

Invitation to the 2022 Annual General Meeting

Proposed Agenda


Welcome. Consideration of minutes of last meeting (available in the members area at the IAC website)


Report of the President


Report of the Secretary-Treasurer
a. Proposal of the Nomination Committee for Slate of Directors for 2022 – 2025 (to be accepted by vote)
b. Presentation of accounts (to be accepted by vote)
c. Proposed budget for 2023 (to be accepted by vote)
d. Proposed annual dues for 2023 (to be accepted by vote)


Summary of Strategic Meeting


Report of Cytotechnology Committee


Report of the Continuing Education Committee


Report of the Editor


Report of the Membership Committee


Actions to be approved and discharged:
a. Treasurer
b. Daily Manager
c. Board of Directors


Report on ICC 2022 Baltimore


Miscellaneous Business

Any member may put forward a point for discussion in good time before the meeting. Please send an email to the Freiburg office if you wish to propose an item for Miscellaneous Business.

Looking forward to seeing you on-line.
Fernando Schmitt, MD, FIAC
Secretary-Treasurer, IAC

Return to top

ICC 2022 in Baltimore

December Webinar 2021: Dr. Sara Monaco

The Central Office has new Rooms

Cytotechnologist Renewal Time

Renewal Timeline

Current Sticker on certificate

Next sticker due in 4-year cycle

Date for renewal

Required Information

2017 – 2020

2020 – 2023

September – December 2020

2017 – 2020

2018 – 2021

2021 – 2024

September – December 2021

2018 – 2020

2019 – 2022

2022 – 2025

September – December 2022

2019 – 2022

2020 – 2023

2023 – 2026

September – December 2023

2020 – 2023

IAC-IARC Collaboration in Cytology

This standardized approach will include the key diagnostic cytopathological features of each particular lesion or neoplasm, which will improve the quality of diagnosis and reporting and subsequent diagnostic procedures. The reporting systems will include options that will recognize the variations in the availability of diagnostic modalities and management in low- and middle-income countries, where cytopathology is particularly useful and is increasingly available in the absence of histopathological services. These international systems will be able to be used worldwide.

The new publications series will be guided by a Cytopathology Editorial Board, consisting of standing members and experts from around the world. The Board will liaise closely with relevant groups internationally to ensure that areas of overlap are managed proactively.

IARC and the IAC share a specific common interest in the development and expansion of internationally standardized diagnostic reporting of cancer and precancerous disorders worldwide.

The IAC is a scientific, not-for-profit organization of cytopathologists, cytotechnologists, and other professionals dedicated to promoting research in and the practice of clinical cytopathology.

IARC is a not-for-profit, specialized agency of the World Health Organization (WHO). IARC was created to promote international collaborative research on cancer, in order to provide a scientific basis for the adoption of effective strategies for cancer prevention and control. A key activity of IARC is the production of the WHO Classification of Tumours, the international standards for cancer diagnosis, which incorporate data from multiple fields, including epidemiology, radiology, histopathology, cytopathology, and genetics.

Visit the IARC